Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||
| Cash from operating activities | 14.88M | 7.21M | 2.82M | 797.02%10.68M | -164.04%-1.53M | 2.39M |
| Net profit before non-cash adjustment | --4.41M | --3.84M | --2M | 11.95%10.5M | 2.99%9.37M | --9.1M |
| Total adjustment of non-cash items | ---300K | ---497K | --81K | 1,039.85%1.1M | 94.17%-116.99K | ---2.01M |
| -Depreciation and amortization | --295K | --289K | --262K | 28.44%477.88K | 9.42%372.05K | --340.01K |
| -Reversal of impairment losses recognized in profit and loss | --0 | --0 | --2K | 112.92%89.56K | 71.31%-693.19K | ---2.42M |
| -Disposal profit | ---- | ---- | ---- | --0 | --0 | --0 |
| -Net exchange gains and losses | ---- | ---- | ---- | --34.11K | --0 | --19.96K |
| -Other non-cash items | ---595K | ---786K | ---183K | 143.91%497.96K | 301.40%204.16K | --50.86K |
| Changes in working capital | --10.78M | --3.87M | --741K | 91.52%-914.83K | -129.37%-10.79M | ---4.7M |
| -Change in receivables | --15M | ---3.59M | --7.26M | 76.46%-3.7M | -86.58%-15.7M | ---8.42M |
| -Change in inventory | ---868K | ---54K | --251K | 116.00%185.93K | -6,072.31%-1.16M | ---18.83K |
| -Change in payables | ---1.94M | --5.72M | ---8.63M | -55.47%2.7M | 16.15%6.06M | --5.22M |
| -Changes in other current assets | ---1.41M | --1.79M | --1.85M | -938.24%-103.64K | 100.83%12.36K | ---1.49M |
| Dividends paid (cash flow from operating activities) | ||||||
| Dividends received (cash flow from operating activities) | ||||||
| Interest paid (cash flow from operating activities) | -72K | -100K | -35K | 0 | 0 | 0 |
| Interest received (cash flow from operating activities) | ||||||
| Tax refund paid | -781K | -561K | -718K | -94.77%-2.85M | -194.74%-1.47M | -497.28K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | --14.03M | --6.55M | --2.07M | 361.02%7.83M | -258.17%-3M | --1.9M |
| Investing cash flow | ||||||
| Net PPE purchase and sale | ---47K | ---638K | ---12K | 54.06%-605.18K | -637.30%-1.32M | ---178.66K |
| Net business purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 |
| Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | --48.44K | ---- | ---- |
| Interest received (cash flow from investment activities) | --274K | --199K | --78K | 45.80%184.56K | 94.42%126.58K | --65.11K |
| Net changes in other investments | ---221K | ---235K | ---217K | -1,610.61%-1.03M | -80.56%67.86K | --349.07K |
| Investing cash flow | --6K | ---674K | ---151K | -24.45%-1.4M | -576.72%-1.12M | --235.52K |
| Financing cash flow | ||||||
| Net issuance payments of debt | ---5.82M | ---1.83M | ---811K | 63.85%3.96M | 1,376.41%2.42M | ---189.54K |
| Net common stock issuance | --0 | --0 | --23.35M | --0 | --0 | --0 |
| Increase or decrease of lease financing | ---269K | --195K | ---290K | -13.32%-181.55K | -1.66%-160.21K | ---157.58K |
| Cash dividends paid | ---- | ---- | ---- | ---- | ---300K | ---- |
| Interest paid (cash flow from financing activities) | ---420K | ---423K | ---523K | -103.21%-688.37K | -187.12%-338.75K | ---117.98K |
| Net other fund-raising expenses | ---- | ---- | ---- | --886.63K | ---- | ---700K |
| Financing cash flow | ---6.51M | ---2.05M | --21.73M | 145.68%3.98M | 239.07%1.62M | ---1.17M |
| Net cash flow | ||||||
| Beginning cash position | --36.78M | --32.96M | --9.31M | -43.26%3.28M | 20.06%5.78M | --4.81M |
| Current changes in cash | --7.53M | --3.82M | --23.65M | 516.28%10.41M | -358.88%-2.5M | --965.85K |
| Effect of exchange rate changes | ---- | ---- | ---- | ---34.11K | --0 | --0 |
| End cash Position | --44.31M | --36.78M | --32.96M | 316.35%13.65M | -43.26%3.28M | --5.78M |
| Free cash flow | --13.98M | --5.91M | --2.06M | 267.32%7.22M | -351.36%-4.32M | --1.72M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.